papaverine has been researched along with Anxiety Disorders in 2 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
Anxiety Disorders: Persistent and disabling ANXIETY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nelson, JJ | 1 |
De Maio, D | 1 |
1 trial available for papaverine and Anxiety Disorders
Article | Year |
---|---|
Relieving select symptoms of the elderly.
Topics: Age Factors; Aged; Anxiety Disorders; Attitude; Brain; Clinical Trials as Topic; Dementia; Dihydroer | 1975 |
1 other study available for papaverine and Anxiety Disorders
Article | Year |
---|---|
[Clinico-theoretical considerations on the association of trifluoperazine and coronary vasoactive drugs in the treatment of anxiety states in aged cardiopathic patients].
Topics: Anxiety; Anxiety Disorders; Heart Diseases; Humans; Papaverine; Pentaerythritol Tetranitrate; Phenot | 1969 |